AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
T-Cells For The Win With Adaptimmune's Adrian Rawcliffe
Business Of Biotech
Intro
This chapter highlights the FDA's approval of the first TCR cell therapy for synovial sarcoma, a groundbreaking development in cancer treatment. It discusses the significance of this milestone for patients and the efforts of developer Adaptimmune in advancing innovative cell therapies.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode